Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled trial of early insulin treatment in very low birth weight neonates
2004-002170-34Phase 4Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Feb 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of insulin aspart in neonatal hyperglycemia (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: 28-day mortality. Started Feb 2006; status: completed.
02
Drugs
insulin aspart
03
Conditions
neonatal hyperglycemia
Beyond the preview
Go deeper on 2004-002170-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002170-34.